RDHL insider transaction filings

RedHill Biopharma Ltd. — 2 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-13. Screen RDHL transaction legs live →

FiledFormInsiderReported transactionsSource
2026-07-134Raday Gilead — Chief Operating OfficerSale (S): 14,130,000 @ $0.00 · Option exercise (M): 28,150,000 (derivative) @ $0EDGAR
2026-04-224Raday Gilead — Chief Operating OfficerSale (S): 15,740,000 @ $0.00 · Option exercise (M): 30,780,000 (derivative) @ $0EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=RDHL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →